The small molecule cmo/cdmo global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Small Molecule CMO/CDMO Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The small molecule cmo/cdmo market size has grown strongly in recent years. It will grow from $46.83 billion in 2023 to $50.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to favorable government support, cost-effective solutions, growing complexity in drug development, industry consolidation, focus on core competencies.
The small molecule cmo/cdmo market size is expected to see strong growth in the next few years. It will grow to $68.04 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rise in drug pipelines, globalization of pharmaceutical operations, demand for flexible manufacturing, regulatory compliance expertise, biopharmaceutical convergence. Major trends in the forecast period include sustainable and green manufacturing practices, increased collaboration and partnerships, personalized medicine and niche therapies, rise in virtual and virtual-to-reality companies, integration of digital technologies, rapid response manufacturing.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report
Scope Of Small Molecule CMO/CDMO Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Small Molecule CMO/CDMO Market Overview
Market Drivers –
The rising demand for pharmaceuticals is expected to propel the growth of the small-molecule CMO/CDMO market going forward. The pharmaceutical industry is a sector that involves the discovery, development, and production of drugs and medicines by both governmental and private entities. Small-molecule CMO/CDMO is used in the pharmaceutical industry to outsource various services, including the development, manufacturing, and packaging of small-molecule drugs, allowing pharmaceutical companies to reduce costs, save time, and streamline processes. For instance, in May 2021, according to reports published by IQVIA Inc., a US-based pharmaceutical company, the projected total expenditure on pharmaceuticals in the US is anticipated to range between $380 to $400 billion by the year 2025, up from $359 billion in 2020, reflecting a compound annual growth rate of 3%. Therefore, the rising demand for pharmaceuticals is driving the growth of the small-molecule CMO/CDMO market.
Market Trends –
Major companies operating in the small-molecule CMO/CDMO market are focusing on innovative technologies, such as the state-of-the-art small-molecule platform in Shanghai, to elevate CDMO services. The state-of-the-art small-molecule platform represents the forefront of technological innovations to develop and produce small-molecule drugs and to create safer, more effective, and more efficiently produced pharmaceutical compounds. For instance, in June 2023, Porton Pharma Solutions Ltd., a China-based pharmaceutical company, launched a state-of-the-art small-molecule platform in Shanghai, elevating CDMO services. A state-of-the-art small molecule platform embodies a holistic approach, combining cutting-edge technologies and methodologies to advance the entire lifecycle of small molecule pharmaceuticals and one-stop-shop solutions, an end-to-end platform, flexibility and availability, and digital transformation.
The small molecule cmo/cdmo market covered in this report is segmented –
1) By Product: Small Molecule Drug Product, Small Molecule API
2) By Stage Type: Clinical, Commercial, Preclinical
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics
4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders
Get an inside scoop of the small molecule cmo/cdmo market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13733&type=smp
Regional Insights –
North America was the largest region in the Small Molecule CMO/CDMO market in 2023. The regions covered in the small molecule cmo/cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the small molecule cmo/cdmo market report are Patheon NV (Thermo Fisher Scientific), GlaxoSmithKline, Johnson Matthey plc, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc. , Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Avid Bioservices Inc., Dishman Carbogen Amcis Ltd, ProChem Inc., Metrics Contract Services
Table of Contents
1. Executive Summary
2. Small Molecule CMO/CDMO Market Report Structure
3. Small Molecule CMO/CDMO Market Trends And Strategies
4. Small Molecule CMO/CDMO Market – Macro Economic Scenario
5. Small Molecule CMO/CDMO Market Size And Growth
…..
27. Small Molecule CMO/CDMO Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
